These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18334084)

  • 1. A rapid simple approach to screening pharmaceutical products using ultra-performance LC coupled to time-of-flight mass spectrometry and pattern recognition.
    Plumb RS; Jones MD; Rainville PD; Nicholson JK
    J Chromatogr Sci; 2008 Mar; 46(3):193-8. PubMed ID: 18334084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies.
    Plumb RS; Potts WB; Rainville PD; Alden PG; Shave DH; Baynham G; Mazzeo JR
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2139-52. PubMed ID: 18543375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rapid detection and identification of the impurities of simvastatin using high resolution sub 2 microm particle LC coupled to hybrid quadrupole time of flight MS operating with alternating high-low collision energy.
    Plumb RS; Jones MD; Rainville P; Castro-Perez JM
    J Sep Sci; 2007 Nov; 30(16):2666-75. PubMed ID: 17868177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Impurity-Profiling Workflow with the Combination of Flash-Chromatography, UHPLC-MS, and Multivariate Data Analysis for Highly Pure Drugs: A Study on the Synthetic Cannabinoid MDMB-CHMICA.
    Münster-Müller S; Zimmermann R; Pütz M
    Anal Chem; 2018 Sep; 90(17):10559-10567. PubMed ID: 30079731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API).
    Borman PJ; Chatfield MJ; Crowley EL; Eckers C; Elder DP; Francey SW; Laures AM; Wolff JC
    J Pharm Biomed Anal; 2008 Dec; 48(4):1082-9. PubMed ID: 18835674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel rapamycin derivatives as low-level impurities in active pharmaceutical ingredients.
    Zech SG; Carr M; Mohemmad QK; Narasimhan NI; Murray C; Rozamus LW; Dalgarno DC
    J Antibiot (Tokyo); 2011 Sep; 64(9):649-54. PubMed ID: 21792211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-target impurity profiling of marketplace Cetirizine using high-resolution mass spectrometry and multivariate data analysis.
    Zhou Z
    Rapid Commun Mass Spectrom; 2016 Sep; 30(17):1941-50. PubMed ID: 27384394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced monitoring of biopharmaceutical product purity using liquid chromatography-mass spectrometry.
    Laursen K; Justesen U; Rasmussen MA
    J Chromatogr A; 2011 Jul; 1218(28):4340-8. PubMed ID: 21621780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix effect screening for cloud-point extraction combined with liquid chromatography coupled to mass spectrometry: Bioanalysis of pharmaceuticals.
    Kojro G; Rudzki PJ; Pisklak DM; Giebułtowicz J
    J Chromatogr A; 2019 Apr; 1591():44-54. PubMed ID: 30679045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing.
    Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Rome S; Schubert MA; Aerts L; De Beer T
    Eur J Pharm Biopharm; 2018 Jun; 127():92-103. PubMed ID: 29452241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of a two-dimensional liquid chromatography-supercritical fluid chromatography-mass spectrometry (2D-LC-SFS-MS) system to assess "in-vivo" inter-conversion of chiral drug molecules.
    Goel M; Larson E; Venkatramani CJ; Al-Sayah MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():89-95. PubMed ID: 29579733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of sub-2-microm particle liquid chromatography-operated high mobile linear velocities coupled to orthogonal accelerated time-of-flight mass spectrometry for the analysis of ranitidine and its impurities.
    Jones MD; Plumb RS
    J Sep Sci; 2006 Nov; 29(16):2409-20. PubMed ID: 17154121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
    Ermer J; Vogel M
    Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and determination of drugs in human saliva utilizing microextraction by packed sorbent and liquid chromatography-tandem mass spectrometry.
    Abdel-Rehim A; Abdel-Rehim M
    Biomed Chromatogr; 2013 Sep; 27(9):1188-91. PubMed ID: 23629973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design for the transfer of a validated liquid chromatography/tandem mass spectrometry analytical method for the determination of antimicrobial residues in honey from low-resolution to high-resolution mass spectrometry.
    El Hawari K; Al Iskandarani M; Mompelat S; Hurtaud-Pessel D; Verdon E
    Rapid Commun Mass Spectrom; 2017 Jul; 31(13):1103-1110. PubMed ID: 28488287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography-tandem mass spectrometry of bioactive pharmaceutical compounds in the aquatic environment--a decade's activities.
    Hao C; Clement R; Yang P
    Anal Bioanal Chem; 2007 Feb; 387(4):1247-57. PubMed ID: 17221236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Validated and Stability-Indicating LC-DAD and LC-MS/MS Methods for Determination of Avanafil in Pharmaceutical Preparations and Identification of a Novel Degradation Product by LCMS-IT-TOF.
    Can NÖ
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30029473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.